Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Oxycodone
Drug ID BADD_D01645
Description Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917.[A178696] It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label] The first oxycodone containing product, Percodan, was approved by the FDA on April 12, 1950.[L6460]
Indications and Usage For the treatment of diarrhoea, pulmonary oedema and for the relief of moderate to moderately severe pain.
Marketing Status Prescription; Discontinued
ATC Code N02AA05
DrugBank ID DB00497
KEGG ID D05312
MeSH ID D010098
PubChem ID 5284603
TTD Drug ID D07WPQ
NDC Product Code 68071-5055; 0904-7180; 65162-047; 24510-115; 24510-130; 67651-0304; 65162-050; 71335-1023; 67651-0306; 67651-0305; 71335-0981; 24510-140; 71335-1080; 65162-051; 24510-120; 65162-048; 67877-625; 71335-0677; 65162-049; 67651-0303; 24510-110; 67877-623; 0904-6966; 67651-0302
Synonyms Oxycodone | Dihydrone | Oxycone | Dihydrohydroxycodeinone | Oxycodeinon | Eucodal | Theocodin | Oxycodone Hydrochloride | Oxycontin | Pancodine | Dinarkon | Oxiconum
Chemical Information
Molecular Formula C18H21NO4
CAS Registry Number 76-42-6
SMILES CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactoid reaction24.06.03.007; 10.01.07.003--Not Available
Androgen deficiency21.16.02.001; 05.05.02.008--
Anger19.04.02.0010.000186%Not Available
Angioedema10.01.05.009; 23.04.01.001--Not Available
Anhedonia19.15.02.007--Not Available
Ankle fracture15.08.03.005; 12.04.01.0050.000325%
Anuria20.01.03.0020.000036%Not Available
Anxiety19.06.02.002--
Apathy19.04.04.0020.000093%Not Available
Aphasia17.02.03.001; 19.21.01.0010.000186%
Aphonia22.02.05.024; 17.02.08.009; 19.19.01.0020.000093%
Apnoea22.02.01.0010.000232%
Arteriosclerosis24.04.02.0010.000024%Not Available
Arthralgia15.01.02.001--
Arthritis15.01.01.0010.000279%
Arthropathy15.01.01.0030.000325%Not Available
Aspartate aminotransferase increased13.03.01.006--
Asphyxia12.01.08.011; 22.02.02.0010.000024%Not Available
Aspiration22.02.07.0070.000036%
Asthenia08.01.01.001--Not Available
Asthma22.03.01.002; 10.01.03.0100.000371%Not Available
Atrial fibrillation02.03.03.002--
Atrial flutter02.03.03.0030.000093%
Azotaemia20.01.01.001--Not Available
Back disorder15.03.01.0140.000093%Not Available
Back pain15.03.04.005--
Biliary colic09.02.01.001--Not Available
Bladder dilatation20.03.01.0070.000139%Not Available
Blindness17.17.01.003; 06.02.02.0010.000186%Not Available
Blister23.03.01.001; 12.01.06.002--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 23 Pages